Press Release 2007

Sabinsa Corporation today announced that it has completed construction of a $6 million manufacturing facility in Hyderabad, India. The state-of-the-art building and its 100 estimated employees will manufacture herbal extracts and phytochemicals for world markets including the U.S., Europe and Japan.

Located in India's Genome Valley, the new plant covers an area of 200,000-square-feet with a dedicated 60,000-square-foot area which houses a series of testing labs and manufacturing equipment to ensure optimum quality control, in addition to providing headquarters for Sabinsa's research and development operations. Sabinsa currently operates five additional manufacturing facilities throughout India. This plant, like the others uses effluent water treatment systems and is environmentally conscious and friendly.

"Increased demand for our scientifically backed ingredients coupled with tremendous business opportunity in the Genome Valley presented an ideal opportunity to grow our business and establish a new manufacturing plant in India," said Dr. Muhammed Majeed, founder of Sabinsa Corporation. "We are pleased to have the tools to better serve our customers while providing a range of employment opportunities that will allow both Sabinsa and the local economy to flourish."

    VISIT US

  • Sabinsa Canada Inc.
    6800 Kitimat Road, Unit 28,
    Mississauga, ON L5N 5M1
    Canada

  • +1 905-286-6616
  • +1 437-988-1663
  • info@sabinsa.ca

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.